These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 17614878)
1. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Medina-Tato DA; Ward SG; Watson ML Immunology; 2007 Aug; 121(4):448-61. PubMed ID: 17614878 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. Marwick JA; Chung KF; Adcock IM Ther Adv Respir Dis; 2010 Feb; 4(1):19-34. PubMed ID: 20051446 [TBL] [Abstract][Full Text] [Related]
3. PI3K inhibition in inflammation: Toward tailored therapies for specific diseases. Ghigo A; Damilano F; Braccini L; Hirsch E Bioessays; 2010 Mar; 32(3):185-196. PubMed ID: 20162662 [TBL] [Abstract][Full Text] [Related]
4. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Rommel C; Camps M; Ji H Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298 [TBL] [Abstract][Full Text] [Related]
5. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity. Fruman DA Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231 [TBL] [Abstract][Full Text] [Related]
6. Inflammation to Pulmonary Diseases. Lee KY; Ito K; Maneechotesuwan K Mediators Inflamm; 2016; 2016():7401245. PubMed ID: 27293320 [No Abstract] [Full Text] [Related]
7. Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies. Foster JG; Blunt MD; Carter E; Ward SG Pharmacol Rev; 2012 Oct; 64(4):1027-54. PubMed ID: 23023033 [TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives. Vyas P; Vohora D Curr Drug Targets; 2017; 18(14):1622-1640. PubMed ID: 27739372 [TBL] [Abstract][Full Text] [Related]
9. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Barberis L; Hirsch E Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175 [TBL] [Abstract][Full Text] [Related]
10. PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms. Lupieri A; Smirnova N; Malet N; Gayral S; Laffargue M Adv Biol Regul; 2015 Sep; 59():4-18. PubMed ID: 26238239 [TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma. Park SJ; Min KH; Lee YC Respirology; 2008 Nov; 13(6):764-71. PubMed ID: 18811876 [TBL] [Abstract][Full Text] [Related]